Glenmark Pharmaceuticals Limited

Name: Glenmark Pharmaceuticals Limited | See Recent Shipments | ImportGenius
Creator: ImportGenius
License: https://creativecommons.org/licenses/by-nc-nd/4.0/

US Customs records for Glenmark Pharmaceuticals Limited, a supplier based in India. See their past imports and exports, including shipments to Glenmark Pharmaceuticals Inc. Usa in Penn Allentown, New Jersey.

Call ImportGenius Sales

Join ImportGenius to see the import/export activity of every company in the United States. Track your competitors, get freight forwarding leads, enforce exclusivity agreements, learn more about your overseas factories, and much more. Instant signup.

Get United States data for $229

Total Shipments

5,894

Trading Partners

Top Partner

GLENMARK PHARMACEUTICALS INC.,USA

Ports

Top Port

New York/Newark Area, Newark, New Jersey

Contact Info

Glenmark Pharmaceuticals Limited

Plot No 2 Isez Phase Iipharma Zone Mumbai Na 400099 In

Glenmark Pharmaceuticals Limited Records

Get a complete supplier history

Updated: 2026-06-02

Total shipments from 2006-11-01 to 2026-06-03

Precise data and chart data points are only available to paid subscribers

Supplier Shipments

Top Trading Partners

Legend

Top Ports

Legend

New York/Newark Area, Newark, New Jersey
Norfolk, Virginia
New York, New York
Savannah, Georgia
Miami, Florida

Total shipments from 2006-11-01 to 2026-06-03

Precise data and chart data points are only available to paid subscribers

Supplier Shipments

#	Bill of Lading	Product	Importer	Supplier	Arrival Date	Country of Origin	Gross Weight KGS	Quantity
1	MAEU270094286	45 PACKAGES 3637 CARTONS PHARMACEUTICALS ASUNDER SOLIFENACIN SUCCINATE TAB 10MG 30 NDC CODE68462038730 FDA PRODUCT CODE NO. 6 1 KCA 72 H. T. S NO. 3004 49 00 70 ANDA NO. 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE URGENCY AND URINARY FREQUEN, CY NITROGLYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE68462063945 FDA PRODUCT CODE NO. 66S C A 28 H. T. S NO. 3004.90.9020 ANDA NO .206391 THERAPEUTIC USE MEDICATION USED FORHEART FAILUREHIGH BLOOD PRESSUREAND TO TRE AT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART ROSUVASTATIN TAB 40MG 30 NDC CODE68462026430 FDA PRODUCT CODE NO.61 J C A 16 H. T. S NO. 3004.49.00.10ANDA NO. 079172 THERAPEUTICE USE TO TREA T HIGH CHOLESTEROL AND RELATED CONDITIONS AND TO PREVENT CARDIOVASCULAR DISEASE FENOFIBRATE CAP 67MG 100 NDC CODE68462058001 FDA PRODUCT CODE NO. 61 JCE 09 H. T. S NO. 3004.90.92.20 ANDA NO. 205566 THERAPEUTICE USE INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDLC TOTALC TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA FROVATRIPTAN SUCCINATE TAB 2.5MG 9 NDC CODE68462069497 FDA PRODUCT CODE NO.60 L C A 93 H. T. S NO. 3004.90.92.28 ANDA NO.204730 THERAPEUTICE USE USETHE TREATMENT OFMIGRAINE HEADACHES AND FOR SHORT TERM PREVENTION OF MENSTRUAL MIGRAINE ROSUVASTATIN TAB 40MG 500 NDC CODE68462026405 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS AND TO PREVENT CARDIOVASCULAR DISEASE GABAPENTIN TAB 600MG 500 NDC CODE68462012605 FDA PRODUCTCODENO 61 N C A 69 HTS NO.3004.90.9236 A NDA NO.77662 THERAPEUTICE USEANTICONVULSANTNICARDIPINE HCL CAP 30MG 90 NDC CODE684 62012190 FDA PRODUCT CODE NO. 62 O C E 48 H. T. S NO. 3004.90.9220 ANDA NO. 216357 THERAPEUTICE USE CARDIOVASCULAR AGENT CALCIUM CHANNEL BLOCKER COMMERCIAL CUSTOM INVOICE NO. F22787000089 DT. 29.04.2026 F22787000090 DT. 29.04.2026 F22787000091 DT. 29.04.2026 F22787000092 DT. 29.04.2026 F22787000094 DT. 29.04.2026 F22787000093 DT. 29.04.2026 F22787000095 DT. 29.04.2026 SBILL NO 2815373 DT29APR26 SBILL NO 2815574 DT29APR26 SBILL NO 2815388 DT29APR26 SBILL NO 2815372 DT29APR26 SBILL NO 2815382 DT29APR26 SBILL NO 2815385 DT29APR26 SBILL NO 2816302 DT29APR26 GROSS WT.10699.251 KGS NET WT.7486.043 KGS 32 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE XXXXXXXXXXXXTY3 XXXXXXXX SPECIALTY S.A. XXXXXXXXXXX (GSSA) PLACE DU PORT 2 NEUCHATEL 2000 SWITZERLAND	GLENMARK PHARMACEUTICALS INC.,USA	GLENMARK PHARMACEUTICALS LIMITED	2026-06-02	India	10722 Kgs	13 PKG
2	MAEU270094287	41 PACKAGES 1980 CARTONS PHARMACEUTICALS ASUNDER DROSPIRENONEEE TAB 30.02MG 84 NDC CODE68462072029 FDA PRODUCT CODE NO. 65 J D A 39 H. T. S NO. 3006.60.00.00 ANDA NO. 204296 THERAPEUTICE USE ORAL CONTRACEPTIVENORETHINDRONE TAB 0.35MG 84 NDC CODE684 62030529 FDA PRODUCT CODE NO. 65 J C A 26, H. T. S NO. 3006.60.00.00 ANDA NO.91209 THERAPEUTICE USE PREVENTION OF PREGNANCY. HEATHER TAB 0.35MG 84 NDC CODE68462030329 FDA PRODUCT CODE NO. 65 J C A 24 H. T. S NO.3006.60.00.00 ANDA NO.90454 THERAPEUTICE USE PREVENTION OF PREGNANCY. COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT. 29.04.2 026 F22752000412 DT. 29.04.2026 F22752000455 DT. 30.04.2026 SBILL NO 2867652 DT 30APR2026 SBILL NO 2867654 DT 30APR2026 SBILL NO 2867937 DT 30APR2026 GROSS WT.5539.000 KGSNET WT.3917.520 KGS 02 DATA LOGGERS HU MIDITY65 SET TEMPERATURE 18 DEGREES TEMPERXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX	GLENMARK PHARMACEUTICALS INC.,USA	GLENMARK PHARMACEUTICALS LIMITED	2026-06-02	India	5550 Kgs	12 PKG
3	MAEU270094292	40 PACKAGES 1988 CARTONS PHARMACEUTICALS ASUNDER ALYACEN 135 TAB 10.035MG 84 NDC C ODE68462039429 FDA PRODUCT CODE NO. 65 J D A 24 H. T. S NO. 3006.60.00.00 ANDA NO. 091634 THERAPEUTICE USE ORALCONTRACEPTIVE DROSPIRENONEEE TAB 30.02MG 84 NDC CODE68462 072029 FDA PRODUCT CODE NO. 65 J D A 39 H., T. S NO. 3006.60.00.00 ANDA NO. 204296 TH ERAPEUTICE USE ORAL CONTRACEPTIVE COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT. 29.04.2026 F22752000405 DT. 29.04.2026 SBILLNO 2819718 DT 29APR2026 SBILL NO 2820773 DT 29APR2026 GROSS WT.6199.280 KGS NET WT. 4638.770 KGS 02 DATA LOGGERS HUMIDITY65 SET XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX	GLENMARK PHARMACEUTICALS INC.,USA	GLENMARK PHARMACEUTICALS LIMITED	2026-06-02	India	6212 Kgs	11 PKG
4	MAEU270094240	39 PALLETS 2340 CARTONS PHARMACEUTICALS AS UNDER ESTRADIOL VAG INSERTS 10MCG 8 NDC CODE68462071171 FDA PRODUCT CODE NO. 64 G C A 28 H. T. S NO. 3006.60.00.00 ANDA NO.210264 THERAPEUTICE USETHE TREATMENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. COMMERCIAL CUSTOM INVOICE NO. F22752000373 DT. 27.04.2026 SBILL NO 2, 756309 DT 27APR2026 GROSS WT.6040.320 KGS NET WT.4548.960 KGS 02 DATA LOGGERS HUMIDITY65SET TEMPERATURE 18 DEGREES TEMPERATURE RANG E 15 DEGREES TO 25 DEGREES NOTIFY PARTY2 XXE NEW JERSEY MAHWAH 07430 USA	GLENMARK PHARMACEUTICALS INC.,USA	GLENMARK PHARMACEUTICALS LTD	2026-06-02	India	6053 Kgs	39 PKG
5	YASVBOM0080412	PHARMACEUTICAL PRODUCTS	GLENMARK PHARMACEUTICALS LIMITED	GLENMARK PHARMACEUTICALS LTD.	2026-06-02	India	7957 Kgs	43 PKG
6	YASVBOM0080410	PHARMACEUTICAL PRODUCTS	GLENMARK PHARMACEUTICALS LIMITED	GLENMARK PHARMACEUTICALS LTD.	2026-06-02	India	5475 Kgs	40 PKG
7	YASVBOM0080409	PHARMACEUTICAL PRODUCTS	GLENMARK PHARMACEUTICALS LIMITED	GLENMARK PHARMACEUTICALS LTD.	2026-06-02	India	8243 Kgs	50 PKG
8	YASVBOM0080408	PHARMACEUTICAL PRODUCTS	GLENMARK PHARMACEUTICALS LIMITED	GLENMARK PHARMACEUTICALS LTD.	2026-06-02	India	10806 Kgs	48 PKG
9	YASVBOM0080407	PHARMACEUTICAL PRODUCTS	GLENMARK PHARMACEUTICALS LIMITED	GLENMARK PHARMACEUTICALS LTD.	2026-06-02	India	7287 Kgs	40 PKG
10	YASVBOM0080405	PHARMACEUTICAL PRODUCTS	GLENMARK PHARMACEUTICALS LIMITED	GLENMARK PHARMACEUTICALS LTD.	2026-06-02	India	8460 Kgs	46 PKG

#	Importer	Last Address	Most Recent	No. of Containers	Gross Weight KGS
1	GLENMARK PHARMACEUTICALS INC.,USA	New York/Newark Area, Newark, New Jersey	2026-06-02	2914	17110167 Kgs
2	GLENMARK PHARMACEUTICALS LIMITED	New York/Newark Area, Newark, New Jersey	2026-06-02	1129	7487476 Kgs
3	GLENMARK PHARMACEUTICALS INC., US	New York/Newark Area, Newark, New Jersey	2025-07-08	1021	5769064 Kgs
4	AMERISOURCE HEALTH SERVICES	Norfolk, Virginia	2026-05-14	273	1944363 Kgs
5	NORTHSTAR DISTRIBUTION CENTER	Savannah, Georgia	2026-05-29	249	1529204 Kgs

#	Supplier	Last Address	Most Recent	No. of Containers	Gross Weight KGS
1	GLENMARK PHARMACEUTICALS LIMITED	India	2026-06-02	1129	7487476
2	GLENMARK PHARMACEUTICAL LTD	India	2016-06-19	129	923214
3	N/A	India	2026-04-10	65	417352
4	STRIDES SHASUN LIMITED	Oman	2018-09-05	48	408571
5	GLAND PHARMA LIMITED	India	2026-06-02	27	114943

More data available to paid subscribers

Sample Shipment From Glenmark Pharmaceuticals Limited

Bill of Lading MAEU270094286

Arrival Date: 2026-06-02

Container Number: MNBU4401638

Cargo #1
Description 45 PACKAGES 3637 CARTONS PHARMACEUTICALS AS UNDER SOLIFENACIN SUCCINATE TAB 10MG 30 NDC CODE68462038730 FDA PRODUCT CODE NO. 6 1 KCA 72 H. T. S NO. 3004 49 00 70 ANDA NO . 209239 INDICATED FOR THE TREATMENT OF OVE RACTIVE BLADDER WITH SYMPTOMS OF URGE URINA RY INCONTINENCE URGENCY AND URINARY FREQUEN CY NITROGLYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE68462063945 FDA PRODUCT CODE NO. 66 S C A 28 H. T. S NO. 3004.90.9020 ANDA NO .206391 THERAPEUTIC USE MEDICATION USED FOR HEART FAILUREHIGH BLOOD PRESSUREAND TO TRE AT AND PREVENT CHEST PAIN FROM NOT ENOUGH B LOOD FLOW TO THE HEART ROSUVASTATIN TAB 40MG 30 NDC CODE68462026430 FDA PRODUCT COD E NO.61 J C A 16 H. T. S NO. 3004.49.00.10 ANDA NO. 079172 THERAPEUTICE USE TO TREA T HIGH CHOLESTEROL AND RELATED CONDITIONS A ND TO PREVENT CARDIOVASCULAR DISEASE FEN OFIBRATE CAP 67MG 100 NDC CODE68462058001 F DA PRODUCT CODE NO. 61 JCE 09 H. T. S NO. 3004.90.92.20 ANDA NO. 205566 THERAPEUTICE USE INDICATED AS ADJUNCTIVE THERAPY TO DIE T FOR THE REDUCTION OF LDLC TOTALC TRIGLYCE RIDES AND APO B IN DULT PATIENTS WITH PRMA RY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEM IA FROVATRIPTAN SUCCINATE TAB 2.5MG 9 ND C CODE68462069497 FDA PRODUCT CODE NO.60 L C A 93 H. T. S NO. 3004.90.92.28 ANDA NO.2 04730 THERAPEUTICE USE USETHE TREATMENT OF MIGRAINE HEADACHES AND FOR SHORT TERM PRE VENTION OF MENSTRUAL MIGRAINE ROSUVASTAT IN TAB 40MG 500 NDC CODE68462026405 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHO LESTEROL AND RELATED CONDITIONS AND TO PREV ENT CARDIOVASCULAR DISEASE GABAPENTIN TA B 600MG 500 NDC CODE68462012605 FDA PRODUCT CODENO 61 N C A 69 HTS NO.3004.90.9236 A NDA NO.77662 THERAPEUTICE USEANTICONVULSANT NICARDIPINE HCL CAP 30MG 90 NDC CODE684 62012190 FDA PRODUCT CODE NO. 62 O C E 48 H. T. S NO. 3004.90.9220 ANDA NO. 216357 T HERAPEUTICE USE CARDIOVASCULAR AGENT CALCIU M CHANNEL BLOCKER COMMERCIAL CUSTOM INV OICE NO. F22787000089 DT. 29.04.2026 F22787 000090 DT. 29.04.2026 F22787000091 DT. 29.04 .2026 F22787000092 DT. 29.04.2026 F22787000 094 DT. 29.04.2026 F22787000093 DT. 29.04.20 26 F22787000095 DT. 29.04.2026 SBILL NO 28 15373 DT29APR26 SBILL NO 2815574 DT29APR26 SBILL NO 2815388 DT29APR26 SBILL NO 2815372 DT29APR26 SBILL NO 2815382 DT29APR26 SBILL NO 2815385 DT29APR26 SBILL NO 2816302 DT29AP R26 GROSS WT.10699.251 KGS NET WT.7486.043 KGS 32 DATA LOGGERS HUMIDITY65 SET TEMP ERATURE 18 DEGREES TEMPERATURE XXXXXXXXXXXX TY3 XXXXXXXX SPECIALTY S.A. XXXXXXXXXXX (GS SA) PLACE DU PORT 2 NEUCHATEL 2000 SWITZE RLAND
Keywords pharmaceuticals	HS-Code DATA UNAVAILABLE	Piece Count 45

Length 480	Height 108
Width 96	Load Status Loaded
Seal IN3497058, ISEZ000660	Equipment Description R1
Type 40 Foot Integral Reefer Container, Mechanically refrigerated and heated	Type of Service Container Yard
Container Type 40 Foot Integral Reefer Container, Mechanically refrigerated and heated	Marks & Numbers MARKS AND NUMBERS MANUFACTURE D FOR GLENMA RK PHARMACEUTICAL S INC. USA 749 SOUTH PA ROUTE 100 SUITE A ALLENTOWN

Carrier MAERSK LINE	Carrier Code MAEU
Carrier Address 2 GIRALDA FARMS, MADISON AVE.	Carrier Contact Number DATA UNAVAILABLE
Ship Registered In DATA UNAVAILABLE	Foreign Port JAWAHARLAL NEHRU
Voyage Number 617W	Country of Origin INDIA
Vessel Name CORNELIA MAERSK	U.S. Port DATA UNAVAILABLE
Master Bill of Lading MAEU270094286	Weight (LB/KG) 23592.065888671877 / 10699.349609375
Quantity 13 PKG	Container Count 1
Place of Receipt JAWAHARLAL NEHRU	Distribution Port DATA UNAVAILABLE
House-v-Master DATA UNAVAILABLE	Measurement DATA UNAVAILABLE
In-Bond Entry-Type DATA UNAVAILABLE	Bill Type Code Regular Bill